US mulls easier access to emergency contraception
December 6, 2011 in Medications
US regulators are considering whether to grant a drug company's request to make emergency contraception available over the counter to people of all ages instead of by prescription.
Currently, the morning-after pill -- which can reduce the chance of pregnancy if taken within 72 hours of unprotected sex -- is available by prescription only to people under 17 in the United States.
Those over 17 can ask for it at a pharmacy counter without a doctor's prescription.
Teva Pharmaceuticals asked the Food and Drug Administration to change its rules to allow its product, Plan B One-Step, to be easily accessible to all ages, and industry watchers expect a decision on Wednesday.
"We believe that this defies good public health sense," said spokeswoman Jeanne Monahan of the Family Research Council, a conservative advocacy group, citing STDs and sexual abuse as possible risks that may be ignored if youths can get the morning-after pill without consulting a doctor.
"Of course we are pro-life and of course that is a major issue on this, but we believe there is a real danger that Plan B can be given to girls and sexually abused and exploited minors under coercion and without their consent," she told AFP.
"The doctor can ask good questions to get to if there is a problem of sexual exploitation. To remove that level of medical supervision to me is removing a huge help to young girls."
Pro-choice advocates have long pressed for greater access to emergency contraception, and voiced hope that the FDA would loosen regulations.
"Hopefully, it will be right on the shelves between the condoms and the pregnancy tests," Kirsten Moore of the Reproductive Health Technologies Project, an advocacy group, was quoted as telling the Washington Post.
"We think it's good news for women's health and long overdue."
An FDA spokeswoman declined to give any details about the impending decision.
(c) 2011 AFP
-
Welsh girls to get morning-after pill for free
Apr 01, 2011 |
not rated yet |
0
-
A new type of pill for emergency contraception
Oct 05, 2010 |
not rated yet |
0
-
U.S. sales of morning-after pill double
Jul 13, 2007 |
not rated yet |
0
-
FDA to allow 'morning-after' pill for 17-year-olds
Apr 22, 2009 |
not rated yet |
0
-
FDA OKs morning-after pill retail sale
Aug 24, 2006 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Merck ends development of Parkinson's disease drug
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.
Medications
22 hours ago |
1 / 5 (1) |
0
J&J expects 10-plus new drug applications by 2017
(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...
Medications
23 hours ago |
5 / 5 (1) |
0
Experts favor US approval of Merck sleeping pill (Update)
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications
May 22, 2013 |
not rated yet |
0
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
May 22, 2013 |
not rated yet |
0
Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine
The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
Medications
May 22, 2013 |
not rated yet |
0
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Driving and hands-free talking lead to spike in errors, study shows
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
Controlling mood through the motions of mitochondria
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
Dec 06, 2011
Rank: 1 / 5 (1)
Dec 07, 2011
Rank: 1 / 5 (3)
Why does your God kill so many "babies"?
Dec 07, 2011
Rank: 3 / 5 (2)
Of course, that's like twisted logic in a country where I can't buy Sudafed off the shelf because someone realized that meth-heads were buying it to make illegal drugs. I swear, if someone found a useful hallucinogen in toothpaste -- even if it took $100,000 per tube to extract it -- it would be off the shelves tomorrow.
@Duude: you are entitled to your opinion. However, abortion is legal in this country. As a result, the FDA has got no business setting random stipulations on the drug.